Case trackerEmerging
AngioDynamics port claims: who can file and what comes next Updates
Updated Oct 6, 2026
Did your AngioDynamics or Navilyst port break, get infected or cause a blood clot? You may be able to file a claim.
Register interestFollow the record
No source-linked updates are available here yet. The case guide has the current information and eligibility details.
Sources
- JPML Transfer Order, In re AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation, MDL No. 3125 (Oct. 3, 2024)JPML transfer order, MDL 3125 · court
- JPML, Pending MDL Dockets by Actions Pending (report date Oct. 1, 2026)JPML pending MDL report, Oct. 1, 2026 · court
- JPML, Pending MDL Dockets by MDL Number (report date Oct. 1, 2026)JPML pending MDLs by number, Oct. 1, 2026 · court
- S.D. Cal., MDL 3125, Stipulated Case Management Order No. 1 (Direct Filing, Service of Process, Attorney Registration), Dkt. 152 (Jan. 27, 2025)MDL 3125 Case Management Order 1 · court
- S.D. Cal., MDL 3125, Case Management Order No. 6 (bellwether selection and profile forms), Dkt. 442 (Oct. 14, 2025)MDL 3125 Case Management Order 6 · court
- S.D. Cal., MDL 3125, Case Management Order No. 7 (common-issue schedule), Dkt. 466 (Oct. 31, 2025)MDL 3125 Case Management Order 7 · court
- S.D. Cal., MDL 3125, Order Granting in Part and Denying in Part Defendants' Motions to Dismiss, Dkt. 239 (Apr. 24, 2025)MDL 3125 order on time-limit motions, Apr. 2025 · court
- S.D. Cal., MDL 3125, Order Granting in Part and Denying in Part Defendants' Motions to Dismiss [Dkts. 384, 385], Dkt. 501 (Nov. 14, 2025)MDL 3125 order on time-limit motions, Nov. 2025 · court
- S.D. Cal., MDL 3125, Parties' Joint Submission on Proposed Plaintiff Fact Sheet, Dkt. 762 (July 21, 2026)MDL 3125 proposed plaintiff fact sheet · court
- S.D. Cal., MDL 3125, Order Setting Briefing Schedule on Motion to Compel, Setting Status Conference, and Governing Discovery Responses, Dkt. 824 (Sept. 22, 2026)MDL 3125 order of Sept. 22, 2026 · court
- S.D. Cal., MDL 3125, Case Management Order No. 8 Governing Discovery Process Relating to Plaintiff Profile Forms, Dkt. 573 (Jan. 16, 2026)MDL 3125 Case Management Order 8 · court
- CourtListener docket, In re AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation, No. 3:24-md-03125 (S.D. Cal.)MDL 3125 docket (CourtListener) · court
- Memorandum of Points and Authorities in Support of Defendants AngioDynamics, Inc. and Navilyst Medical, Inc.'s Motion to Dismiss, MDL 3125, Dkt. 194-1 (Feb. 20, 2025)AngioDynamics' motion to dismiss brief · court
- FDA Medical Device Recall database: Class 2 Device Recall Vortex MP Port (Z-0132-2023)FDA recall: Vortex MP Port (2022) · regulator
- FDA Medical Device Recall database: Class 2 Device Recall Smart Port CT (Z-1466-2021)FDA recall: Smart Port CT (2021) · regulator
- FDA Medical Device Recall database: Class 2 Device Recall BioFlo Port with ENDEXO and PASV Technology (Z-0076-2019)FDA recall: BioFlo Port (2018) · regulator
- openFDA device recall records for recalling firms AngioDynamics and Navilyst (all 410 product records, queried Oct. 5, 2026)openFDA recall records · regulator
- FDA: About Manufacturer and User Facility Device Experience (MAUDE)FDA: About MAUDE · regulator
- openFDA device adverse event (MAUDE) records for AngioDynamics or Navilyst, product code LJT (implanted port), counted by brand name (queried Oct. 5, 2026)openFDA adverse event records · regulator
- National Cancer Institute, NCI Dictionary of Cancer Terms: portNCI Dictionary: port · regulator
- Braun U, et al. Mechanic and surface properties of central-venous port catheters after removal: A comparison of polyurethane and silicon rubber materials. J Mech Behav Biomed Mater. 2016;64:281-91Braun et al., 2016 · study
- Wildgruber M, et al. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm. Eur J Cancer. 2016;59:113-124Wildgruber et al., 2016 · study
- Surov A, et al. Port catheter insufficiency: incidence and clinical-radiological correlations. Onkologie. 2008;31(8-9):455-61Surov et al., 2008 · study
- Goossens GA, et al. Systematic review: malfunction of totally implantable venous access devices in cancer patients. Support Care Cancer. 2011;19(7):883-98Goossens et al., 2011 · study
- ABA Model Rule of Professional Conduct 1.5: FeesABA Model Rule 1.5
- HHS: Your Medical RecordsHHS: Your Medical Records · regulator
- S.D.N.Y. Pro Se FAQ: How long do I have to file my complaint (statute of limitations)?SDNY: filing time limits · court
Want the complete picture?
Read the case guide for eligibility, evidence and your next steps.